In a randomised placebo-controlled crossover trial in women with IIH and no prior migraine, CGRP infusion provoked a headache attack in 71% vs 18% after placebo (17 completed; risk difference 53%, P=0.004); ICP amplitude rose but mean ICP was unchanged.
RCTn = 20
Yiangou et al. Calcitonin gene-related peptide induces headache attacks in people with idiopathic intracranial hypertension